The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.

Condition:   Bioequivalence Interventions:   Drug: Olmesartan Medoxomil 40 mg;   Drug: Olmetec® Sponsors:   Pharmtechnology LLC;   Altasciences Company Inc. Recruiting

Source: ClinicalTrials.gov - May 15, 2019 Category: Research Source Type: clinical trials